Published in Eur J Clin Pharmacol on January 01, 1977
Antidepressants in the general hospital. Can Med Assoc J (1979) 0.75
Do general practitioners "miss" depression in elderly patients? Br Med J (Clin Res Ed) (1986) 2.96
Rates of mitochondrial DNA evolution in sharks are slow compared with mammals. Nature (1992) 2.82
Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition (1997) 1.42
Lichen nitidus and lichen spinulosus or spinous follicular lichen nitidus? Clin Exp Dermatol (2005) 1.41
Non-organic gastrointestinal illness: a medical and psychiatric study. Br J Psychiatry (1980) 1.37
Structural biology and phylogenetic estimation. Nature (1997) 1.34
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry (1967) 1.21
A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Acta Psychiatr Scand Suppl (1989) 1.17
Why smoke fewer cigarettes? Br Med J (Clin Res Ed) (1982) 1.12
Release of leukotrienes during rapid expulsion of Trichinella spiralis from immune rats. Immunology (1987) 1.11
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry (1975) 1.08
A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry (1986) 1.08
Erythrocyte membrane cation carrier in depressive illness. Psychol Med (1973) 1.03
Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol (1987) 1.02
Hydrophobicity and phylogeny. Nature (1995) 1.02
Sleep patterns in depressive states. Br J Med Psychol (1972) 1.01
Rapid flux in plant genomes. Nat Genet (1998) 0.99
A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry (1987) 0.97
Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats. J Immunol (1986) 0.96
Circadian rhythms of water and electrolyte excretion in manic-depressive psychosis. Br J Psychiatry (1969) 0.95
Optimization of the isolation and effective use of mRNA from rat mast cells. J Immunol Methods (1997) 0.92
Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness. Am Rev Respir Dis (1990) 0.90
Short-cycle manic depressive psychosis in mental defectives: a clinical and physiological study. J Ment Defic Res (1976) 0.90
Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry (1979) 0.90
Vitamin D intoxication, with hypernatraemia, potassium and water depletion, and mental depression. Br Med J (1968) 0.90
A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry (1974) 0.88
Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology (1996) 0.88
A biochemical study of short-cycle manic-depressive psychosis in mental defectives. Br J Psychiatry (1976) 0.88
Symptom relief and the placebo effect in the trial of an anti-peptic drug. Gut (1981) 0.88
Erythrocyte membrane cation carrier in mania. Psychol Med (1976) 0.88
Tissue vanadium levels in manic-depressive psychosis. Psychol Med (1984) 0.87
Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med (1976) 0.87
Plasma vanadium concentration in manic-depressive illness. Psychol Med (1982) 0.86
Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychol Med (1977) 0.86
Emotional disturbance following childbirth: clinical findings and urinary excretion of cyclic AMP (adenosine 3'5'cyclic monophosphate). Psychol Med (1979) 0.85
Elevated vanadium content of hair and mania. Biol Psychiatry (1984) 0.84
Plasma magnesium and calcium levels in depressive psychosis. Br J Psychiatry (1972) 0.84
Review: children and companion animals. Child Care Health Dev (1980) 0.83
Fatality due to massive overdose of sodium valproate. Scott Med J (1987) 0.83
Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro. Clin Exp Immunol (1985) 0.83
Attempt to demonstrate an in vivo effect of mianserin hydrochloride on erythrocyte Na+-K+-ATPase activity and cyclic AMP concentration. Br J Clin Pharmacol (1978) 0.83
Use of cupric oxide needles in the prophylaxis of induced copper deficiency in lambs grazing improved hill pastures. Vet Rec (1983) 0.82
The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils. Immunology (1990) 0.82
Trial of digoxin in mania. Lancet (1975) 0.82
Plasma tryptophan concentration in depressive illness and mania. Br J Psychiatry (1976) 0.82
Methylene blue in mania. Biol Psychiatry (1988) 0.82
The use of the SelfCARE(D) as a screening tool for depression in the clients of local authority home care services--a preliminary study. Int J Geriatr Psychiatry (1998) 0.81
The effect of digoxin on the response to lithium therapy in mania. Psychol Med (1982) 0.81
Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry (1986) 0.81
Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord (1983) 0.80
Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacologia (1974) 0.80
Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychol Med (1980) 0.80
Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity. Clin Exp Immunol (1987) 0.80
Changes in erythrocyte sodium and potassium on recovery from a depressive illness. Br J Psychiatry (1971) 0.79
Catecholamine metabolism in affective disorders: excretion of 3-methoxy-4-hydroxymandelic acid in depressive states. Can Psychiatr Assoc J (1972) 0.79
Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue) Lancet (1981) 0.79
Plasma concentrations of protriptyline and clinical effects in depressed women. Br J Psychiatry (1976) 0.79
Kininase activity in experimental pancreatitis. Nature (1966) 0.78
Leucocyte activation initiated by IgE-dependent mechanisms in relation to helminthic parasitic disease and clinical models of asthma. Int Arch Allergy Appl Immunol (1985) 0.78
The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride. Regul Toxicol Pharmacol (2000) 0.78
Enhancement of leukocyte cytotoxicity after exercise-induced asthma. Am Rev Respir Dis (1986) 0.78
Lithium side effects in a routine lithium clinic. Br J Psychiatry (1979) 0.78
Phylogenetic inference from conserved sites alignments. J Exp Zool (1999) 0.78
A double blind placebo controlled trial of ascorbic acid in obesity. Nutr Health (1985) 0.77
Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med (1981) 0.77
Changes in the erythrocyte sodium pump with age. Gerontology (1977) 0.77
Prediction of clinical course of bipolar manic depressive illness treated with lithium. Psychol Med (1980) 0.77
Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness. J Affect Disord (1985) 0.77
Unpleasant taste--a neglected symptom in depression. J Affect Disord (1989) 0.76
Erythrocyte sodium and potassium in depre- ssive illness. J Psychosom Res (1970) 0.76
Cation transport in lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1989) 0.76
A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychol Med (1981) 0.76
Vanadium and manic depressive psychosis. Nutr Health (1984) 0.76
Factor VIII-related antigen and procoagulant activity in manic-depressive patients. J Affect Disord (1983) 0.76
The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments. Psychol Med (1984) 0.76
Some biochemical findings during pregnancy and after delivery in relation to mood change. Psychol Med (1982) 0.75
Profound hypothermia on combined lithium carbonate and diazepam treatment. Br Med J (1977) 0.75
Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes. Immunology (1986) 0.75
Bromocriptine in mania--a placebo-controlled double-blind trial. Br Med J (1980) 0.75
EURODEP study. Br J Psychiatry (1999) 0.75
Tyramine conjugation and antidepressants. Lancet (1989) 0.75
The effect of mianserin on urinary catecholamine excretion in psychiatric patients. Br J Clin Pharmacol (1981) 0.75
A study of plasma tryptophan and tyrosine in mania. Postgrad Med J (1977) 0.75
Plasma total and free tryptophan concentration in 'neurotic' and 'psychotic' depressive patients. Monogr Neural Sci (1976) 0.75
Trace elements in manic depressive psychosis. J Affect Disord (1985) 0.75
Some aspects of the metabolism of tricyclic antidepressants. Postgrad Med J (1976) 0.75
Catalysis of the reduction of vanadate by psychotropic drugs. Neuropharmacology (1983) 0.75